Here, we used cancer genomics and transcriptomics data to systematically investigate the expression and clinical significance of MAEL. We found that MAEL was significantly overexpressed in GC tissues and that high MAEL mRNA levels predict poor survival in GC patients. The gene discussed is MAEL; the disease is gastric cancer.